Download - Planning the Lifecycle of Safety Evaluation
![Page 1: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/1.jpg)
www.diahome.org
Planning the Lifecycle of Safety Evaluation
Brenda Crowe, PhD
Eli Lilly and Company
![Page 2: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/2.jpg)
www.diahome.org
Conference Program Committee
• Brenda Crowe, PhD, Lilly (Co-chair)• Wanju Dai, MD, DrPH, sanofi-aventis (Co-chair)• Gerald Dal Pan, MD, MHS, FDA• Henry “Skip” Francis, MD, FDA• Paul Huckle, MD, GlaxoSmithKline• Robert O’Neill, PhD, FDA• Manfred Oster, MD, sanofi-aventis• George Rochester, PhD, RAC, FDA• Amy Xia, PhD, Amgen
Program Advisors• Walt Offen, PhD, Lilly• Steve Snapinn, PhD, Lilly
![Page 3: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/3.jpg)
www.diahome.org
Conference Co-chairpersons
In addition to the program committee:• Howard Chazin, MD, MBA, FDA• Eileen King, PhD, Procter & Gamble• Judith Racoosin, MD, MPH, FDA• James Hung, PhD, FDA• Henry Hsu, PhD, MPH, FDA• Jesse Berlin, ScD, Johnson & Johnson• Sandra Kweder, MD, FDA
![Page 4: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/4.jpg)
www.diahome.org
Special Thanks
• Constance Burnett, DIA
• Jessica Kusma, DIA
• Debra Michaels, DIA
![Page 5: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/5.jpg)
www.diahome.org
Conference Goals
• Stimulate discussion among FDA and industry participants regarding proactive planning of safety evaluation throughout the lifecycle of drug development.– Includes planning for data collection,
evaluation (including data monitoring committees), integration, analysis (including meta-analysis) and reporting.
![Page 6: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/6.jpg)
www.diahome.org
Program Outline—Day 1
• 9:10 – 10:30: Challenges and Opportunities to Improve Premarketing Safety Planning, Evaluation and Reporting
• 11:00 – noon, 1:30 – 2:30: Combining Safety Data at a Development Program Level—Data Collection and Study Design: Dirt Road Vs. Super Highway
• 2:30 – 3:45: How to Improve Safety Data Analysis and Presentation
• 4:15 – 5:30: Safety Boundaries for Data Monitoring Committees
• 5:30 - 6:30: Reception
![Page 7: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/7.jpg)
www.diahome.org
Program Outline—Day 2
• 8:30 – 8:40: Welcome and Keynote Introduction• 8:40 – 9:30: Keynote Presentation (Janet Woodcock)• 9:30 – 10:30: Introduction and Overview of Meta-
analysis• 11:00 – 12:30: Concurrent sessions (Meta-analysis
of 1. Rare Events and 2. Observational Data)• 1:45 – 3:00: Regulatory Decision Making Based on
Meta-analysis Results• 3:30 – 4:30: Lessons Learned and Path Forward
Panel• 4:35: Conference adjourned
![Page 8: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/8.jpg)
www.diahome.org
Time• Session chairs:
Please synchronize your watches:It is now: ….9:0X am
• Very important: We need to stick to allotted time
![Page 9: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/9.jpg)
www.diahome.org
5minute
![Page 10: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/10.jpg)
www.diahome.org
1minute
![Page 11: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/11.jpg)
www.diahome.org
0minute
![Page 12: Planning the Lifecycle of Safety Evaluation](https://reader036.vdocument.in/reader036/viewer/2022083006/56813b31550346895da3fc2e/html5/thumbnails/12.jpg)
www.diahome.org
-1minute
Stop Now!! Please
You’re killing me!